---
title: "INRX.US (INRX.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INRX.US/news.md"
symbol: "INRX.US"
name: "INRX.US"
parent: "https://longbridge.com/zh-CN/quote/INRX.US.md"
datetime: "2026-03-12T07:27:50.736Z"
locales:
  - [en](https://longbridge.com/en/quote/INRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INRX.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/INRX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/INRX.US/news.md)


# INRX.US (INRX.US) — 相关新闻

### [InSilico Medicine Expects 2025 Losses to Widen; Shares Gain 4%](https://longbridge.com/zh-CN/news/278327366.md)
*2026-03-09T04:45:25.000Z*
> InSilico Medicine Expects 2025 Losses to Widen; Shares Gain 4%

### [09:03 ETIntrinsic Therapeutics Announces Initial Release of Its Next Generation Barricaid Narrow Anchor Device Designed to Reduce Reherniation After Back Surgery](https://longbridge.com/zh-CN/news/277792897.md)
*2026-03-04T14:03:56.000Z*
> Intrinsic Therapeutics, Inc. has launched the Barricaid® Narrow Anchor, a smaller version of its FDA-approved Bone-Ancho

### [Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference | IPHA Stock News](https://longbridge.com/zh-CN/news/276200873.md)
*2026-02-17T22:00:00.000Z*
> Innate Pharma SA, a clinical-stage biotechnology company, will participate in the Leerink Partners Global Healthcare Con